These include: a) the improvement and enhancement
of biocontrol efficacy under commercial conditions; b) the development
of high quality, economical methods of fermentation and
formulation; c) themaintenance of cell viability and biocontrol efficacy in
the formulated product; d) the identification of yeast antagonists that exhibit
a wide spectrum of activity against several different pathogens on
different commodities; e) the establishment of an effective marketing
outlet, preferably by a multinational based company; and f) developing
a fundamental understanding of how biocontrol systems operate and
how the environment affects the interactions between the host, pathogen,
and biocontrol agent as outlined in Fig. 1.